92 results
Search Results
2. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference
3. AGA White Paper: Challenges and Gaps in Innovation for the Performance of Colonoscopy for Screening and Surveillance of Colorectal Cancer
4. AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States
5. AGA White Paper: Optimizing Endoscopic Ultrasound–Guided Tissue Acquisition and Future Directions
6. White Paper AGA: Functional Dyspepsia
7. White Paper AGA: Gastroparesis: Clinical and Regulatory Insights for Clinical Trials
8. White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease
9. White Paper AGA: Drug Development for Eosinophilic Esophagitis
10. White Paper AGA: The Impact of Mental and Psychosocial Factors on the Care of Patients With Inflammatory Bowel Disease
11. AGA White Paper: Training and Implementation of Endoscopic Image Enhancement Technologies
12. White Paper AGA: An Episode-of-Care Framework for the Management of Obesity—Moving Toward High Value, High Quality Care: A Report From the American Gastroenterological Association Institute Obesity Episode of Care and Bundle Initiative Work Group
13. White Paper AGA: POWER — Practice Guide on Obesity and Weight Management, Education, and Resources
14. White Paper AGA: Advanced Imaging in Barrett’s Esophagus
15. A Point-of-Care Paper-based Fingerstick Transaminase Test: Toward Low-cost “Lab-on-a-Chip” Technology for the Developing World
16. The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease
17. Risk of Kidney Failure in Patients With Inflammatory Bowel Disease Undergoing Colectomy: A Nationwide Cohort Study
18. Association Between Celiac Disease and Irritable Bowel Syndrome: A Nationwide Cohort Study
19. Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD
20. Smoking and Alcohol Consumption and Risk of Incident Diverticulitis in Women
21. Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis
22. Province-Wide Ascertainment of Lynch Syndrome in Manitoba
23. Comparative Effectiveness of Biologic Therapies in Preventing Penetrating Complications in Patients With Crohn’s Disease
24. Patients With Microscopic Colitis Are at Higher Risk of Major Adverse Cardiovascular Events: A Matched Cohort Study
25. Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program
26. UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis
27. Development of the Endoscopic Pouch Score for Assessment of Inflammatory Conditions of the Pouch
28. Identifying, understanding and managing fecal urgency in inflammatory bowel diseases
29. Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet
30. Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies
31. Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis
32. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life
33. Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT
34. Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients With Cirrhosis
35. Evidence for Endoscopic Ulcers as Meaningful Surrogate Endpoint for Clinically Significant Upper Gastrointestinal Harm
36. Antibiotic Use Associated With Risk of Colorectal Polyps in a Nationwide Study
37. Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones
38. Association Between Inflammatory Diets, Circulating Markers of Inflammation, and Risk of Diverticulitis
39. Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver Disease
40. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
41. Crohn’s Disease Is Associated With an Increased Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study Using Magnetic Resonance Proton Density Fat Fraction Mapping
42. Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis
43. Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis
44. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests
45. Characteristics of Opioid Prescriptions to Veterans With Cirrhosis
46. Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program
47. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis
48. Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
49. Worldwide Burden of and Trends in Mortality From Gallbladder and Other Biliary Tract Cancers
50. When Should Patients Undergo Genetic Testing for Hereditary Colon Cancer Syndromes?
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.